ADGSOM1 & ADGMIN1  
       
  LAUNCH OF THE 50TH ANNIVERSARY CELEBRATION OF RUKUN NEGARA  
       
  KL SUMMIT 2019  
       
  HAWANA 2018  
       
  AES 2016  
       

 
 
 

March 29, 2024 -Friday

 
  A THRUST FORWARD FOR MALAYSIA & SOUTH KOREA IN THE CLINICAL RESEARCH INDUSTRY

Wednesday 18/01/2017



PETALING JAYA, Jan 18 (Bernama) -- C&R Research Inc., Korea’s largest contract research organization (CRO) and Clinical Research Malaysia (CRM) have signed a Memorandum of Understanding (MoU) to cooperate in promoting clinical trial activities in Malaysia and South Korea.

Malaysia has existing experience, facilities, processes, regulations and manpower in conducting clinical trials for over 20 years. With the current Malaysian Economic Transformation Program (ETP) that targets clinical research as one of its main drivers in economic growth, Malaysia has accelerated its efforts to reach out to foreign players in the clinical research field. With this cooperation, both parties will provide support and valuable resources to complement the needs of each country in terms of business development, clinical trial operations and trainings.

Malaysia stands to benefit through business networking opportunities from South Korean pharmaceutical and biotech companies which may see more trial coming into the country. C&R Research Inc. will enjoy CRM’s complementary feasibility services and support in clinical projects as well as in C&R’s establishment in Malaysia.

The MoU ceremony was witnessed by the Director General of Health, Malaysia, YBhg. Datuk Dr. Noor Hisham, the Deputy Director General of Health (Research & Technical Support), YBhg. Datuk Dr. Shahnaz Murad, Director of the National Clinical Research Centre, Dr. Goh Pik Pin and Dr. Akhmal Yusof, the CEO of CRM. Also present was the Ambassador of the Republic of Korea, HE Dr. Yu Hyun-seok, Finance Attache Ambassador of the Republic of Korea, Mr. Park, Sang-il, KHIDI-ASEAN Director General, Mr. Lee Dong-won, KHIDI-ASEAN Researcher, Mr. Jung Yun-young and Chairman of C&R Research Inc., Mr Yoon Moon-tae.

C&R Research Inc.
As a leading CRO, C&R Research Inc, established in 1997 has grown continuously at high growth rate with the longest history and experience in South Korea.
C&R Research, the first CRO in Korea has leaded the development of Korea CRO industry by providing excellent regulatory and clinical research services for pharmaceutical and healthcare industries encompassing clinical development phase I – III and post approval clinical studies. Additionally C&R Research has strived to provide comprehensive clinical research solutions including e-Clinical solution, Pharmacovigilance, Centralized monitoring, QA, Medical advising and Academy.

For strategic movements, in 2010 C&R China was established in Beijing and in 2012, C&R Research joined in an Asia CRO alliance called, A-PACT (Alliance for Pac-ASIA Clinical Trials) as one of founding members. C&R Research has put effort to enter Asia and global clinical research market actively through strategic partnership and own branch offices. 

Clinical Research Malaysia (CRM)
Established by the Malaysian Ministry of Health in 2012, CRM exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies. 

CRM’s innate understanding of the local clinical research landscape with the international standards of operations coupled with fundamental backing of the government ministries provide us an incomparable advantage to work with partners from the nascent stages of development to materialisation of the end product, in order to deliver better treatment and high skilled job opportunities. 

Source : Clinical Research Malaysia (CRM) 

FOR MORE INFORMATION, PLEASE CONTACT: 
Name: Syed Hamzah Syed Noordin
Business Development 
Clinical Research Malaysia (CRM) 
Tel : 03 – 7960 5153 (Ext 121)
Email : hamzah@clinicalresearch.my 

--BERNAMA


 

 
 
 

Copyright © 2024 MREM . All rights reserved.